Table 5 Smokescreen pilot genotyping sample characteristics - blood or cell line
From: Smokescreen: a targeted genotyping array for addiction research
Study | Description | Samples | Individuals | DNA Source | %Male |
|---|---|---|---|---|---|
Hapmap and 1000 Genomes | CEPH/Utah; Yoruba in Ibadan, Nigeria; Japanese in Tokyo, Japan samples | 188 | 188 | cell line | 50.00 % |
PKTWIN, “588”, SMOFAM | Nicotine metabolism laboratory studies | 343 | 326 | blood | 45.71 % |
Total Exposure Study | Cross sectional study of tobacco exposures | 33 | 32 | blood | 56.25 % |
MA fMRI, Modafinil, ASCC2, ASCC Neural Systems | Genetics and brain structure in smokers | 35 | 34 | blood | 58.82 % |
COGEND | Report of genetic results in smokers | 31 | 30 | blood | 33.33 % |
Positive lab controls | 6 | 1 | cell line |